Compare INDRAPRASTHA MEDICAL with KMC SPECIALITY HOSPITALS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs KMC SPECIALITY HOSPITALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL KMC SPECIALITY HOSPITALS INDRAPRASTHA MEDICAL/
KMC SPECIALITY HOSPITALS
 
P/E (TTM) x 17.6 68.6 25.6% View Chart
P/BV x 2.8 24.3 11.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   KMC SPECIALITY HOSPITALS
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
KMC SPECIALITY HOSPITALS
Mar-20
INDRAPRASTHA MEDICAL/
KMC SPECIALITY HOSPITALS
5-Yr Chart
Click to enlarge
High Rs5219 275.8%   
Low Rs279 319.6%   
Sales per share (Unadj.) Rs90.65.9 1,536.7%  
Earnings per share (Unadj.) Rs4.80.7 660.9%  
Cash flow per share (Unadj.) Rs8.41.0 816.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.23.1 940.5%  
Shares outstanding (eoy) m91.67163.09 56.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.42.3 18.8%   
Avg P/E ratio x8.419.2 43.8%  
P/CF ratio (eoy) x4.813.5 35.5%  
Price / Book Value ratio x1.44.4 30.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,6602,250 162.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,139216 991.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,308962 863.8%  
Other income Rs m714 48.5%   
Total revenues Rs m8,315976 851.9%   
Gross profit Rs m864214 404.4%  
Depreciation Rs m33049 666.3%   
Interest Rs m5911 519.9%   
Profit before tax Rs m482167 288.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4650 92.2%   
Profit after tax Rs m436117 371.5%  
Gross profit margin %10.422.2 46.8%  
Effective tax rate %9.529.7 32.0%   
Net profit margin %5.312.2 43.0%  
BALANCE SHEET DATA
Current assets Rs m1,415177 799.1%   
Current liabilities Rs m1,396124 1,127.1%   
Net working cap to sales %0.25.5 4.1%  
Current ratio x1.01.4 70.9%  
Inventory Days Days235 6.1%  
Debtors Days Days358 436.4%  
Net fixed assets Rs m3,075487 631.4%   
Share capital Rs m917163 562.1%   
"Free" reserves Rs m1,761343 512.8%   
Net worth Rs m2,678507 528.7%   
Long term debt Rs m058 0.0%   
Total assets Rs m4,490664 676.2%  
Interest coverage x9.115.7 58.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.91.4 127.7%   
Return on assets %11.019.4 56.9%  
Return on equity %16.323.2 70.3%  
Return on capital %20.231.6 64.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,4080-   
Fx outflow Rs m3440-   
Net fx Rs m1,0640-   
CASH FLOW
From Operations Rs m865107 808.2%  
From Investments Rs m-402-78 515.5%  
From Financial Activity Rs m-427-36 1,199.0%  
Net Cashflow Rs m35-7 -528.4%  

Share Holding

Indian Promoters % 49.4 75.0 65.9%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 25.0 196.0%  
Shareholders   59,093 51,565 114.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   SHALBY   FORTIS MALAR  KOVAI MEDICAL  THYROCARE TECHNOLOGIES  METROPOLIS HEALTHCARE  



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 8-QTR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS